Abiomed: Another Quarter Of Jaw-Dropping Margins And Cash Flow Generation

About: Abiomed, Inc. (ABMD)
by: Nikolaos Sismanis
This article is exclusive for subscribers.
Nikolaos Sismanis
Long only, Growth, growth at reasonable price, long-term horizon

Abiomed posted strong financials results, which further strengthened its balance sheet.

Management is very optimistic about the future and the company's potential in international markets.

Even after the stock's rally, there is still considerable upside ahead.

Profitable investing is what we, hopefully, all strive to achieve. However, I love investing in companies that, while focused on returning capital to shareholders, are also beneficial to society. Abiomed (NASDAQ:ABMD) could not